Plunkett Research Online: Vivus Inc

VIVUS INC (VVUS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vivus, Inc. is a biopharmaceutical company developing therapeutic drugs for the treatment of obesity, diabetes, sleep apnea, men’s sexual health disorders and pulmonary arterial hypertension (PAH). The firm currently has two approved therapies and one product candidate in active clinical developmen.....



Vivus Inc
Ticker: VVUS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 934-5200
Fax: 650 934-5389
Address: 900 East Hamilton Avenue
Suite 550
Campbell, CA 95008 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Manufacturing
Female Sexual Dysfunction Treatments
Obesity Treatment
Erectile Dysfunction Therapies
Diabetes Treatment
Obstructive Sleep Apnea Therapy
ContactsDescription
Kenneth SuhCEO, Subsidiary/President, Subsidiary
John AmosCEO/Director
See More
Vivus, Inc. is a biopharmaceutical company developing therapeutic drugs for the treatment of obesity, diabetes, sleep apnea, men’s sexual health disorders and pulmonary arterial hypertension (PAH). The firm currently has two approved therapies and one product candidate in active clinical developmen.....See More See More

Auditor: OUM & Co. LLP
Legal Advisor: Hogan Lovells US LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Qsymia
STENDRA
SPEDRA
Tacrolimus
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: